FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1538198175> ?p ?o ?g. }

• W1538198175 endingPage "1728" @default.
• W1538198175 startingPage "1720" @default.
• W1538198175 abstract "To assess the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow transplantation, we studied 1,202 patients with acute nonlymphocytic leukemia (ANL), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) given unmodified marrow grafts from HLA- identical siblings. Proportional hazards regression models using acute GVHD and chronic GVHD as time-dependent covariates demonstrated a significant association of GVHD with a decreased relative risk (RR, 0.33 to 0.42) of relapse in patients with ANL, ALL, and CML transplanted in advanced disease. Among patients developing either acute or chronic GVHD, treatment failure (that is, mortality or relapse) was decreased in patients with ALL transplanted in relapse (RR = 0.70, P less than .033) and CML in blast crisis (RR = 0.37, P less than .009). This effect was independent of age, sex, preparative regimen, GVHD prophylaxis, or length of follow-up. Five-year actuarial estimates were derived for the subset of 657 patients who survived in remission 150 days after transplant and were at risk for development of chronic GVHD. Among patients with ANL in first remission or CML in chronic phase, GVHD had an adverse effect on survival and no apparent influence on relapse. Among patients with ANL and ALL transplanted in relapse, the probability of relapse after day 150 was 74% without [corrected] GVHD, 45% with acute and chronic GVHD, 35% with [corrected] only acute GVHD, and 34% with only chronic GVHD (P less than .001). Actuarial survival in these four GVHD groups was 25%, 34%, 59%, and 62%, respectively (P less than .009). Among patients with CML in acceleration or blast crisis, the probability of relapse after day 150 was 65% without GVHD and 36% with acute and/or chronic GVHD (P less than .017). We conclude that acute and chronic GVHD were associated with a durable antileukemic effect and improved survival in patients transplanted in advanced stages of ALL and CML." @default.
• W1538198175 created "2016-06-24" @default.
• W1538198175 creator A5006925103 @default.
• W1538198175 creator A5011254051 @default.
• W1538198175 creator A5020301269 @default.
• W1538198175 creator A5020910879 @default.
• W1538198175 creator A5032751122 @default.
• W1538198175 creator A5060323697 @default.
• W1538198175 creator A5060783496 @default.
• W1538198175 creator A5070624070 @default.
• W1538198175 creator A5085484980 @default.
• W1538198175 creator A5085787488 @default.
• W1538198175 date "1989-05-01" @default.
• W1538198175 modified "2023-10-03" @default.
• W1538198175 title "Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]" @default.
• W1538198175 cites W143215620 @default.
• W1538198175 cites W1490838907 @default.
• W1538198175 cites W1522048276 @default.
• W1538198175 cites W1539774679 @default.
• W1538198175 cites W1548609628 @default.
• W1538198175 cites W1562876511 @default.
• W1538198175 cites W1596160021 @default.
• W1538198175 cites W1597544321 @default.
• W1538198175 cites W1602008817 @default.
• W1538198175 cites W1905977830 @default.
• W1538198175 cites W1944382470 @default.
• W1538198175 cites W1979300931 @default.
• W1538198175 cites W198186331 @default.
• W1538198175 cites W1992401639 @default.
• W1538198175 cites W2003272849 @default.
• W1538198175 cites W2018535826 @default.
• W1538198175 cites W2062442371 @default.
• W1538198175 cites W2067480394 @default.
• W1538198175 cites W2113989770 @default.
• W1538198175 cites W2264531153 @default.
• W1538198175 cites W2330491673 @default.
• W1538198175 cites W2337969406 @default.
• W1538198175 cites W2396957136 @default.
• W1538198175 cites W2400068632 @default.
• W1538198175 cites W2403701385 @default.
• W1538198175 cites W2412019915 @default.
• W1538198175 cites W2412055789 @default.
• W1538198175 cites W2417914160 @default.
• W1538198175 cites W2419538306 @default.
• W1538198175 cites W2438498684 @default.
• W1538198175 cites W2576986565 @default.
• W1538198175 cites W33772365 @default.
• W1538198175 cites W975735119 @default.
• W1538198175 cites W2470092782 @default.
• W1538198175 cites W2995133996 @default.
• W1538198175 doi "https://doi.org/10.1182/blood.v73.6.1720.bloodjournal7361720" @default.
• W1538198175 hasPublicationYear "1989" @default.
• W1538198175 type Work @default.
• W1538198175 sameAs 1538198175 @default.
• W1538198175 citedByCount "78" @default.
• W1538198175 countsByYear W15381981752013 @default.
• W1538198175 countsByYear W15381981752015 @default.
• W1538198175 countsByYear W15381981752019 @default.
• W1538198175 crossrefType "journal-article" @default.
• W1538198175 hasAuthorship W1538198175A5006925103 @default.
• W1538198175 hasAuthorship W1538198175A5011254051 @default.
• W1538198175 hasAuthorship W1538198175A5020301269 @default.
• W1538198175 hasAuthorship W1538198175A5020910879 @default.
• W1538198175 hasAuthorship W1538198175A5032751122 @default.
• W1538198175 hasAuthorship W1538198175A5060323697 @default.
• W1538198175 hasAuthorship W1538198175A5060783496 @default.
• W1538198175 hasAuthorship W1538198175A5070624070 @default.
• W1538198175 hasAuthorship W1538198175A5085484980 @default.
• W1538198175 hasAuthorship W1538198175A5085787488 @default.
• W1538198175 hasBestOaLocation W15381981751 @default.
• W1538198175 hasConcept C126322002 @default.
• W1538198175 hasConcept C203014093 @default.
• W1538198175 hasConcept C2776863199 @default.
• W1538198175 hasConcept C2776960273 @default.
• W1538198175 hasConcept C2777938653 @default.
• W1538198175 hasConcept C2778461978 @default.
• W1538198175 hasConcept C2779972918 @default.
• W1538198175 hasConcept C2780007613 @default.
• W1538198175 hasConcept C2781071720 @default.
• W1538198175 hasConcept C2781107101 @default.
• W1538198175 hasConcept C2909962599 @default.
• W1538198175 hasConcept C2911091166 @default.
• W1538198175 hasConcept C71924100 @default.
• W1538198175 hasConcept C90924648 @default.
• W1538198175 hasConceptScore W1538198175C126322002 @default.
• W1538198175 hasConceptScore W1538198175C203014093 @default.
• W1538198175 hasConceptScore W1538198175C2776863199 @default.
• W1538198175 hasConceptScore W1538198175C2776960273 @default.
• W1538198175 hasConceptScore W1538198175C2777938653 @default.
• W1538198175 hasConceptScore W1538198175C2778461978 @default.
• W1538198175 hasConceptScore W1538198175C2779972918 @default.
• W1538198175 hasConceptScore W1538198175C2780007613 @default.
• W1538198175 hasConceptScore W1538198175C2781071720 @default.
• W1538198175 hasConceptScore W1538198175C2781107101 @default.
• W1538198175 hasConceptScore W1538198175C2909962599 @default.
• W1538198175 hasConceptScore W1538198175C2911091166 @default.
• W1538198175 hasConceptScore W1538198175C71924100 @default.
• W1538198175 hasConceptScore W1538198175C90924648 @default.

• next